Remote Patient Monitoring Systems Market Size, Share, and Trends 2024 to 2034

The global remote patient monitoring systems market size was USD 6.17 billion in 2023, estimated at USD 7.32 billion in 2024 and is anticipated to reach around USD 38.74 billion by 2034, expanding at a CAGR of 18% from 2024 to 2034.

  • Last Updated : May 2024
  • Report Code : 1390
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Remote Patient Monitoring Systems Market 

5.1. COVID-19 Landscape: Remote Patient Monitoring Systems Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Remote Patient Monitoring Systems Market, By Product

8.1. Remote Patient Monitoring Systems Market, by Product Type, 2024-2034

8.1.1. Specialized Monitors

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Vital Sign Monitors

8.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Remote Patient Monitoring Systems Market, By Application

9.1. Remote Patient Monitoring Systems Market, by Application, 2024-2034

9.1.1. Diabetes

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Cancer

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Cardiovascular Diseases

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Weight Management

9.1.4.1. Market Revenue and Forecast (2021-2034)

9.1.5. Bronchitis

9.1.5.1. Market Revenue and Forecast (2021-2034)

9.1.6. Sleep Disorder

9.1.6.1. Market Revenue and Forecast (2021-2034)

9.1.7. Dehydration

9.1.7.1. Market Revenue and Forecast (2021-2034)

9.1.8. Virus

9.1.8.1. Market Revenue and Forecast (2021-2034)

9.1.9. Hypertension

9.1.9.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Remote Patient Monitoring Systems Market, By End Use 

10.1. Remote Patient Monitoring Systems Market, by End Use, 2024-2034

10.1.1. Hospital Patients

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Ambulatory Patients

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Home Healthcare

10.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Remote Patient Monitoring Systems Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2021-2034)

11.1.2. Market Revenue and Forecast, by Application (2021-2034)

11.1.3. Market Revenue and Forecast, by End Use (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.1.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.1.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.6.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.7.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.6.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.7.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.6.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.7.3. Market Revenue and Forecast, by End Use (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.5.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.5.5.3. Market Revenue and Forecast, by End Use (2021-2034)

Chapter 12. Company Profiles

12.1. Abbott Laboratories

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Aerotel Medical Systems

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. AMD Global Telemedicine

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Baxter International Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Boston Scientific Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. GE Healthcare

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Masimo Corporation

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Medtronic PLC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. F. Hoffmann-La Roche AG

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Omron Corporation

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client